Global Medical Refrigerators Market

Cardiovascular devices are used to monitor and control the irregular heartbeats and heart rhythm disorders. The main types in the cardiovascular devices market are cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, and cardiac assist devices and equipment. Defibrillators are devices that restore the normal heartbeat by sending an electric pulse or shock to the heart. They are used to prevent or correct an arrhythmia, a heartbeat that is uneven or slow or fast. The type of expenditure is public, or private. The products used are instruments/equipment, and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The cardiovascular devices market research report is one of a series of new reports from The Business Research Company that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global cardiovascular devices market grew from $59.55 billion in 2022 to $64.39 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiovascular devices market is expected to grow to $83.35 billion in 2027 at a CAGR of 6.7%. Leadless pacemakers are being used for certain medical conditions such as slow heart rate (bradycardia), as they provide a less-invasive alternative to conventional pacemakers. A leadless pacemaker is a self-contained device that is inserted in the right ventricle of the heart without incisional access, leads, or a surgical pocket. Furthermore, the medical procedure for a leadless pacemaker can be performed in under 30 minutes, with few postprocedural restrictions. These devices are gaining popularity as they eliminate complications related to lead placement which includes cardiac perforation, pneumothorax, and lead dislodgement. Major companies manufacturing leadless pacemakers are Medtronic and Abbott. Major companies in the cardiovascular devices market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc., and Becton Dickinson. North America was the largest region in the global cardiovascular devices market in 2022. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cardiovascular devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cardiovascular devices market is segmented - 1) By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system and damaged or blocked valves and vessels. The main product types in the cardiovascular surgery devices and equipment are beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables. Cardiopulmonary bypass equipment is used in open-heart surgeries and is operated by perfectionists. The various applications are congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and other applications. These are used in home and ambulatory care, hospitals, diagnostic laboratories, and research laboratories. The cardiovascular surgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiovascular surgery devices and equipment market statistics, including cardiovascular surgery devices and equipment industry global market size, regional shares, competitors with a cardiovascular surgery devices and equipment market share, detailed cardiovascular surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular surgery devices and equipment industry. This cardiovascular surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global cardiovascular surgery devices and equipment market size will grow from $1.68 billion in 2022 to $1.75 billion in 2023 at a compound annual growth rate (CAGR) of 3.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiovascular surgery devices and equipment market size is expected to grow to $1.91 billion in 2027 at a CAGR of 2.2%. The rising geriatric population along with the rising deaths related to cardiovascular disorders is driving the cardiovascular surgical devices market. According to American Heart Association (AHA), in the US, approximately 43.7 million aged above 60 suffered from cardiovascular disorders. It is also reported by AHA that death related to cardiac diseases amount to 17.3 million per year and is expected to rise to more than 23.6 million by 2030, worldwide. Due to these factors, a higher number of surgeries are being performed, thereby driving the market. The cardiovascular surgical devices market may be restrained due to stringent and longer approval processes by the regulatory authorities. According to a researcher from Harvard Business School, innovative first-mover products such as implantable defibrillators or transcatheter heart valves are delayed for approvals by FDA, thereby adding to the development cost to the manufacturer. For new cardiovascular devices (first-entrants), the innovator spends 7.2 months longer than the first follow-on innovator. For example, Edwards Lifesciences trans-catheter heart valve was approved in Europe 4 years before it was approved in the USA. The study also estimated the financial loss associated with the delay in getting the approval. The delay may cost firms an average of $6.7 million to the already existing $94 million average prices to introduce a new medical device to market, thereby hampering companies’ pursuit of innovations. Companies in the cardiovascular surgery devices and equipment market are investing in second-generation bioresorbable stents and as well rectifying the glitches which occurred in the earlier version of bioresorbable stents. This advancing segment is poised to garner $247 million by 2025. Due to the all-new device features such as thinner strut thicknesses, faster resorption times, and better radial force, these are expected to grow at a higher growth rate. A higher elective procedure volume due to the less-invasive nature of PCIs, when compared to coronary artery bypass grafting, is expected to drive bioresorbable stents adoption. For instance, Amaranth Medical has developed three medical devices with thinner strut thickness, the latest bearing a magnitude of 100 microns. The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) made public, its priority list for medical device guidance documents. This would allow the companies in promoting innovation and as well save them from the stringent consequences of non-approval of any product. Thus, a clearer and transparent approval method would drive the cardiovascular surgical devices market in the future. Major players in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, C.R.Bard, Abiomed, St.Jude medical, Angiodynamics Inc., Transmedics, Terumo cardiovascular systems corporation, and Edwards Life Science Corporation. North America was the largest region in the global cardiovascular surgery devices and equipment market in 2022. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cardiovascular surgery devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The cardiovascular surgery devices and equipment market consist of sales of perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment, and cardiac ablation devices that are used for cardiovascular surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cardiovascular surgery devices and equipment market is segmented - 1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables 2) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories 3) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications

The spinal surgery devices are used to prevent the motion of the spine when fusion occurs between two or more vertebrae. The main product types in spinal surgery devices and equipment are spine biologics, surgical spinal decompression, vertebral compression fracture treatment products, non-fusion, and fusion. Spine biologics are materials that are used in spine surgery. The spinal surgery devices and equipment are used to perform various surgeries such as open surgeries and minimally invasive surgeries. These are used by hospitals, ambulatory service centres, and orthopedic centres. The spinal surgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides spinal surgery devices and equipment market statistics, including spinal surgery devices and equipment industry global market size, regional shares, competitors with a spinal surgery devices and equipment market share, detailed spinal surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the spinal surgery devices and equipment industry. This spinal surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global spinal surgery devices and equipment market size will grow from $12.56 billion in 2022 to $13.3 billion in 2023 at a compound annual growth rate (CAGR) of 5.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The spinal surgery devices and equipment market size is expected to grow from $15.83 billion in 2027 at a CAGR of 4.5%. Elderly people are a major driving factor for the spinal surgery devices and equipment market as they are more prone to spinal complications. Spinal disorders majorly affect the geriatric population and result in spinal deformities and pain. As per UN estimates, the worldwide geriatric population will double by 2050 to reach an estimated value of more than 2.1 billion boosting the market growth in the future. An increasing trend in the aged populations worldwide will provide a lucrative growth to the spinal implants and devices. The high cost of treatment restrains the spinal surgery devices and equipment market from reaching its maximum potential growth. According to a study conducted over a year to analyze cost variations, the total cost of the surgeries at the hospitals was found to vary between $27, 000 and $129,000. More than $90 billion a year is spent on treating lower back pain alone. Due to the steadily increasing cost of procedures, the rate of implementing spinal surgery devices has come down this a major restraint for the large-scale hospitals, clinics as well as new entrants for the market. Implementing Nano-technology to improve the quality, precision, and speed of the work is the latest trend in the spinal surgery devices market. Nanoparticles possess unique chemical, biological and physical properties which enables them to perform a wide variety of cellular and subcellular tasks. Spinal pathology is a major field of study for nanotechnology. To fully implement Nano-technology, hospitals and clinics are waiting for FDA regulations and exploring options to reduce costs. Vallum Corporation, a medical device company announced that it received clearance from the American Food and Drug Administration (FDA) for its polyetheretherketone (PEEK) spinal fusion device which has a Nano textured surface. The spinal surgery devices and equipment market has a huge potential to grow but stringent regulatory policies are restricting their growth. Currently, US Food and Drug Administration (FDA) classifies the devices into class II, this class consists primarily of devices that are intended to provide immobilization and stabilization of spinal segments. All devices under this class have to comply with the material standards, mechanical testing standards, and biocompatibility standards. Due to stringent regulations laid by US FDA, product recalls are common and may impact the growth of this market as well. In November 2021, United Healthcare had issued some regulatory policies for spinal fusion enhancement products that include demineralized bone matrix (DBM) without added products listed as unproven and not medically necessary, Autografts, The InFUSE/MASTERGRAFT™ Posterolateral Revision Device System used with MASTERGRAFT according to U.S. Food and Drug Administration (FDA) indications in individuals who meet all the criteria, Allograft based products Infuse® Bone Graft (Recombinant human bone morphogenetic protein-2 (rhBMP-2) of the lumbar spine are used when all the specified criteria are followed. These are are the stringent regulations in the spinal surgery devices and equipment market that restrict the growth of the spinal surgery devices and equipment. In November 2021, Globus Medical Inc GMED.N, a medical technology company acquired NuVasive Inc NUVA.O for a deal amount of $3 billion. With this acquisition, the companies expand their portfolio in the spine surgery devices market. NuVasive Inc is a company manufacturing spinal surgery devices based in the United States. Major players in the spinal surgery devices and equipment market are Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, Globus Medical Inc., Alphatec Spine Inc., Nuvasive Inc., Orthofix International N.V, K2M Group Holdings Inc., and Titan Spine. North America was the largest region in global spinal surgery devices and equipment market in 2022. Western Europe was the second-largest region in global spinal surgery devices and equipment market. The regions covered in the spinal surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the spinal surgery devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The spinal surgery devices and equipment market consist of sales of instruments such as pedicle screws, rods, connectors, plates, and interbody cages that are used for Spinal surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global spinal surgery devices and equipment market is segmented - 1) By Product Type: Spine Biologics, Surgical Spinal Decompression, Vertebral Compression Fracture Treatment Products, Non-Fusion, Fusion 2) By Application: Hospital, Ambulatory Service Centers, Orthopedic Centers 3) By Type of Surgery: Open Surgeries, Minimally Invasive Surgeries

Hand-held surgical devices and equipment are nonpowered, hand-held, or hand-manipulated devices such as scalpels, forceps, retractors, intended to be used in various general surgical procedures. The main products of handheld surgical devices are scalpels, forceps, retractors, dilators, graspers, and others. The forceps are handheld instruments used for holding objects. The various applications involved are neurosurgery, cardiovascular, orthopedic, plastic and reconstructive surgery, obstetrics and gynecology, and others that are used by various end-users such as hospitals, specialized clinics, long-term care centres, ambulatory surgery centres, and others. The handheld surgical devices market research report is one of a series of new reports from The Business Research Company that provides handheld surgical devices market statistics, including handheld surgical devices industry global market size, regional shares, competitors with a handheld surgical devices market share, detailed handheld surgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the handheld surgical devices industry. This handheld surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global handheld surgical devices and equipment market size will grow from $6.07 billion in 2022 to $6.59 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The handheld surgical devices and equipment market size is expected to grow to $8.18 billion in 2027 at a CAGR of 5.6%. Increasing demand for aesthetic surgeries drives the handheld surgical devices and equipment market. The demand for aesthetic surgeries can be attributed to an increase in per capita disposable income. According to the ASPS data 2021, more than 15.5 million cosmetics procedures were performed in 2020 alone. Rhinoplasty (a nose job) was the top cosmetic surgery in 2020, with more than 352,000 surgeries performed. The competitive pricing among manufacturers will restrain the handheld surgical devices market. An increasing number of local manufacturers are offering handheld surgical instruments at lower prices compared to major global manufacturers, as a result, companies are competing heavily on price and often need high sales volumes to be profitable. The use of handheld devices and equipment in minimally invasive surgeries is increasing. The low cost of handheld instruments compared to robotic systems is the major factor for the increasing use of these devices in most surgical settings. Technical advancements in handheld surgical instruments are increasingly adopted by surgeons due to the improvement in the ease of use of these instruments. Medical devices are classified as Class I, Class II, and Class III devices by FDA based on their risks and the regulatory controls necessary to provide a reasonable assurance of safety and effectiveness. Hand-held surgical devices are nonpowered, hand-held, or hand-manipulated devices such as scalpels, forceps, retractors, intended to be used in various general surgical procedures. Hand-held surgical devices are categorized as Class I medical devices. Class I devices generally have the lowest risk to the patient and/or user. These devices are exempted from the premarket notification procedures 510(k). In October 2022, Aspen Surgical Products, a portfolio company of US-based Audax Private Equity, acquired Symmetry Surgical for an undisclosed amount. The acquisition would augment Aspen’s portfolio with additional brands and diversify its portfolio. Symmetry Surgical is a US-based manufacturer of surgical instrumentation. Major players in the handheld surgical devices market are B. Braun Melsungen AG, Medtronic, Smith & Nephew, Johnson & Johnson Services Inc., Integra Life Sciences Corporation, Zimmer Biomet, CooperSurgical Inc., Becton, Dickinson and Company, and Moria. North America was the largest region in global handheld surgical devices market in 2022. Western Europe was the second-largest region in global handheld surgical devices market. The regions covered in the handheld surgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the handheld surgical devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The handheld surgical devices and equipment market consists of sales of spatulas, dilators, graspers, auxiliary instruments, cutter instruments, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global handheld surgical devices and equipment market is segmented - 1) By Product: Scalpels, Forceps, Retractor, Dilators, Graspers, Other Products 2) By End-User: Hospitals, Specialized Clinics, Long-Term Care Centers, Ambulatory Surgery Centers, Other End Users 3) By Application, Neurosurgery, Cardiovascular, Orthopedic, Plastic & Reconstructive Surgery, Obstetrics & Gynecology, Other Applications

Neurosurgery devices and equipment are used to perform neurosurgical procedures that are concerned with the diagnosis, prevention, and treatment of disorders affecting any portion of the nervous system. The main device types of neurosurgery devices and equipment are the neuroendoscope, stereotactic systems, aneurysm clips, neurostimulation devices, cerebrospinal fluid management devices, neurosurgical evacuation devices, neurosurgical navigation systems, neurosurgery surgical power tools, and others (ultrasonic aspirators, surgical instruments). The neuroendoscope is a device that allows neurosurgeons to perform less invasive procedures and surgical approaches in a manner that minimizes disruption to surrounding tissues. The surgery types are intracranial surgery, endonasal neurosurgery, and spinal surgery. The various end-users are hospitals and ambulatory surgical centres. The neurosurgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides neurosurgery devices and equipment market statistics, including neurosurgery devices and equipment industry global market size, regional shares, competitors with a neurosurgery devices and equipment market share, detailed neurosurgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the neurosurgery devices and equipment industry. This neurosurgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global neurosurgery devices and equipment market size will grow from $7.17 billion in 2022 to $8.12 billion in 2023 at a compound annual growth rate (CAGR) of 13.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The neurosurgery devices and equipment market size is expected to grow to $12.93 billion in 2027 at a CAGR of 12.3%. The rise in neurological disorders is driving the neurosurgery devices market. A neurological disorder is caused due to the effect on the nervous system which includes the spinal cord, and brain. These disorders include epilepsy and Alzheimer's. According to an article on US Pharmacist, out of the most common neurological disorders, stroke accounts for 51.3%, Alzheimer’s disease 21.4%, Epilepsy 11.6%, traumatic brain injury 6.8%, Parkinson’s disease 4.7%, and brain tumor 2.8%. Furthermore, 1.2 million people are frequently diagnosed with adult-onset brain disorders. An increase in these disorders is driving the growth of the neurosurgery devices and equipment market. According to the Alzheimers Association, millions of Americans have Alzheimer’s or other dementias. As the size and proportion of the U.S. population age 65 and older continue to increase, the number of Americans with Alzheimer’s will grow from 6.2 million in 2021 to 13.8 million by 2060. The stringent US FDA approval process is restraining the Neurosurgery devices market. US FDA takes around 6 months to approve the premarket submissions to demonstrate the device and check if the device is safe and effective. Most of the neurosurgery devices should get premarket approval from the FDA before entering into the market. For example, In the US, only 2,800 (31%) medical devices have cleared the FDA premarket submissions, and the remaining 69% are rejected. However, the technical sections’ assessment is done simultaneously and therefore the manufacturers should identify the time taking steps and plan the work accordingly and plan an estimated date of approval. Also, the license validity and renewal of the application take a toll on the manufacturer and add to the existing regulatory burden. Therefore, the manufacturers of neurosurgical devices should plan well and communicate effectively to minimize the costs and reduce timelines. Minimally invasive surgical procedures and approaches are the new frontiers in neurosurgery as they result in less pain than open surgeries, shorter recovery times, less scarring, increase surgeon mobility and reduce equipment costs. Neuroendoscopy is a minimally invasive neurosurgical procedure performed through neurosurgery devices to correct hydrocephalus, remove tumors, treat vascular disease, and manage other disorders. Neurosurgery device manufacturers are innovating and integrating technologies for advanced endoscope-assisted neurosurgery to provide efficient minimally invasive surgeries, operative procedures, clinical advances, and new technological developments. For instance, end-users such as hospitals, ambulatory surgical centres, and others are using smartphones with endoscopes for performing safe and efficient endoscope-assisted neurosurgery. In New York-Presbyterian Hospital/Columbia University Medical Center, minimally invasive neurosurgeries are preferred over open surgeries with the help of specialized instruments and technologies such as a camera-assisted endoscope, high-powered operating microscope, computer-assisted navigation system, and others to treat conditions in adults and children. The European Commission adopted two new regulations for medical devices to enhance safety, take effective measures in the event of concerns, and improve traceability. These regulations provide the medical device manufacturers with a stronger mandate for assessment of medical devices by independent notified bodies, a unique identification number for improving traceability throughout the supply chain, availability of clinical data on devices, and provides a central database to provide patients, healthcare professionals and the public with comprehensive information on products. These rules help manufacturers to meet the standards, safety requirements and to make better-informed decisions. Major players in the neurosurgery devices and equipment market are Medtronic, Boston Scientific Corporation, Stryker, Conmed Corporation, Smith & Nephew, Integra LifeSciences, Olympus Corporation, NICo., Karl Storz GmbH & Co. KG, and Richard Wolf GmbH. North America was the largest region in the global neurosurgery devices and equipment market in 2022. Asia-Pacific was the second-largest region in the neurosurgery devices and equipment market. The regions covered in the global neurosurgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the neurosurgery devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The neurosurgery devices and equipment market consists of sales of neurostimulation devices, neuroendoscope, cerebrospinal fluid management devices, neurosurgical evacuation device, neurosurgery surgical power tools, ultrasonic aspirators, and surgical instruments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global neurosurgery devices and equipment market is segmented - 1) By Device Type: Neuroendoscope, Stereotactic Systems, Aneurysm Clips, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, Neurosurgical Evacuation Device, Neurosurgical Navigation Systems, Neurosurgery Surgical Power Tools, Others(Ultrasonic Aspirators, Surgical Instruments) 2) By Surgery Type: Intracranial Surgery, Endonasal Neurosurgery, Spinal Surgery 3) By End User: Hospitals, Ambulatory Surgical Centers

Robotic surgery devices help doctors perform complex minimally invasive operations with precision and flexibility. The main product and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centres. The robotic surgery devices market research report is one of a series of new reports from The Business Research Company that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global robotic surgery devices market size will grow from $6 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global robotic surgery devices market size is expected to grow from $11.65 billion in 2027 at a CAGR of 14.2%. The rise in demand for minimally invasive technology is driving the robotic surgery devices market. Minimally Invasive (MI) surgery devices are equipped with imaging and catheter technologies that can be easily inserted into any part of the body. Robotic surgery procedures are usually associated with minimally invasive surgeries. These technologies are mainly used for heart, laparoscopy, orthopedic, gynecological, and urological surgeries. Robotic surgeries were introduced to reduce patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to the Intuitive Surgical company report, there is a 24% growth year on year for instruments and accessories. For robotic systems, the company has gained 16% growth and the overall robotic surgery devices market is growing at a rate of 13% -16%. The Intuitive Surgical company estimates that more than 1.2 million surgical procedures were done by using their robotic systems. Consumer preferences are changing, and hospitals are adopting robotic surgery devices to create more value and cost-effective surgical procedures. Expensive robotic surgery is hampering the robotic surgery devices market. Robotic surgery is comparatively more expensive than other traditional ways of surgeries as it is associated with a lot of complications, requires highly trained senior doctors to operate robotic systems/instruments, complex technical operations, and maintenance. A single robotic system costs around $2 million and the surgery costs about a range of $3000 - $6000. The annual maintenance cost of robotic surgery devices usually costs between $100,000 - $170,000. The largest robotic surgery device manufacturer Intuitive Surgical supplies the single-use or disposable surgical tools used for robotic arms for surgeries. This is one of the reasons that robotic surgeries are more costly. The huge cost associated with robotic surgeries is therefore hindering the market growth. The advances in surgical products and technologies in the health care industry are creating more opportunities in the robotic surgery devices market. Increasing investments in R&D is helping investors to create value for the customers by producing medical-surgical products like robotic surgery devices by using the latest technologies. With the use of robotic systems that are equipped with optical imaging, surgical tools, instruments, and accessories, the surgeries are made easier. Some of the surgical advances that are creating more value and opportunity in the healthcare industry include 3-D high definition endoscope (Multi-Angle Rear-Viewing Endoscopic tool) devices for Brain surgery, Smart surgical glasses (equipped with a video camera and Head-mounted monitor) that act like computers, and can use for live observation of surgeries, surgical robots with artificial intelligence that acts as doctors, and humanoid robots which are used for highly critical surgeries in eye and brain. The other advanced surgical tool is remote robotics, which is used to assist with surgery from any remote location. Therefore, robotic surgery devices are playing an important role in the healthcare industry with their technological advancements and innovations. In February 2020, Medtronic PLC., a US-based medical device manufacturer, acquired Digital Surgery for an undisclosed amount. The acquisition would help Medtronic in clinical decision support and reduce its cost. It will also help them to grow in the robotic surgery vertical. Digital Surgery is a UK-based manufacturer of digital surgical tools. Major players in the robotic surgery devices market are Intuitive Surgical, Stryker, Medtronic, Smith & Nephew, TransEnterix, Mazor Robotics, Medrobotics, Accuray, THINK Surgical, and TINAVI Medical Technology Co. Ltd. North America was the largest region in the robotic surgery devices market in 2022. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the global robotic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global robotic surgery devices market is segmented - 1) By Product and Service: Robotic systems, Instruments & Accessories, Services 2) By Surgery Type: Urological surgery, Gynecological surgery, Orthopedic surgery, Neurosurgery, Other Surgery Types 3) By End User: Hospitals, Ambulatory Surgery Centers

Electrosurgical devices and equipment are used for cutting, sealing, and coagulating tissue during a variety of open and laparoscopic surgical procedures. The main products of the electrosurgical devices are electrosurgery generators, electrosurgery instruments and accessories, argon, and smoke management systems. Electrosurgery generators facilitate therapeutic endoscopy by supplying the high-frequency electrical current required to use endoscopic accessories. The applications involved are general surgery, gynecology surgery, urologic surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, and neurosurgery. The various end-users are hospitals, specialized clinics, and ambulatory surgery centres. The electrosurgical devices market research report is one of a series of new reports from The Business Research Company that provides electrosurgical devices market statistics, including electrosurgical devices industry global market size, regional shares, competitors with a electrosurgical devices market share, detailed electrosurgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrosurgical devices industry. This electrosurgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global electrosurgical devices and equipment market size will grow from $8.7 billion in 2022 to $9.39 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The electrosurgical devices and equipment market size is expected to grow to $11.45 billion in 2027 at a compound annual growth rate (CAGR) of 5.1%. The increasing prevalence rate of chronic diseases contributed significantly to the growth of the electrosurgical devices and equipment market. The electrosurgical devices are used in the surgery of many life-threatening diseases such as skin cancer, small basal cell carcinomas, squamous cell carcinoma, wound surgery, skin surgery, non-cancerous moles, dentistry, and others. There has been an increase in the number of skin diseases worldwide. For example, in 2021, according to the American Cancer Society, approximately 608,570 Americans died from cancer which was almost 1600 deaths per day.. According to WHO, the global burden of major chronic diseases currently accounts for 43% of all diseases and is set to rise to 60% by 2020. According to a United Nations’ report on world population aging, globally the 60+ aged population is projected to grow by 56% to reach 1.4 billion. The growth of the aging population and rising chronic disease incidence will contribute to increased hospitalization. The increase in the patient pool is expected to rise the demand for electrosurgical devices and equipment. The high incidence of product recalls is one of the factors restraining the electrosurgical devices and equipment market growth. The medical device industry is seeing a significant spike in product recalls during recent years due to defective devices, software issues, mislabeling issues, and quality issues. The electrosurgical devices and equipment market is a minor part of the medical device market and hence, product recall in the electrosurgical market is quite often. For example, in October 2021, Xodus Medical recalled its electrosurgical tip cleaner due to the issue with pouch seal and steril barrier in the tip cleaner. Zimmer Biomet, a medical device company recalled it is class 1 SPF PLUS-Mini and SPF XL IIB Implantable Spinal Fusion Stimulators due to high levels of potentially harmful chemicals which may be toxic to tissues and organs. FDA Safety Communication notice was Magellan Diagnostics and LeadCare of Meridian Bioscience, Inc. for its LeadCare Testing Systems for giving inaccurate test results. Electrosurgery is the application of a high-frequency electric current on biological tissue to create. Technological advances have led to the development of modern ESUs that deliver the medically useful thermal effect. This system is capable of continuously monitoring current and voltage, deriving parameters such as power and tissue resistance, and analyzing them. Depending on the desired treatment outcome, these devices can also keep the operating parameters constant or change them in a targeted manner through control and regulation. Electrosurgical equipment manufacturers should consider investing ESUs to increase market share in the market. The regulatory changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes are leading to increased costs of electrosurgical equipment product development and supply to healthcare services organizations. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. According to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR. In the USA, the U.S. Department of Health and Human Services and Center for Devices and Radiological Health are regulating electrosurgical devices under US FDA. There are two main ways that manufacturers can follow for premarket approval. One way consists of conducting clinical studies and submitting a premarket approval (PMA) application that includes evidence providing reasonable assurance that the device is safe and effective. The other way involves submitting a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. The FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The delays in product releases and additional costs incurred due to stringent approval processes put a strain on investments relating to electrosurgical equipment new product development resulting in potential loss of revenue. Major players in the electrosurgical devices market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen AG, Medtronic PLC., Smith and Nephew, Boston Scientific, Stryker Corporation, ATMOS Inc., Heal Force Bio-Meditech Holdings Limited, and Erbe Elektromedizin GmbH. North America was the largest region in the global electrosurgical devices market in 2022. Western Europe was the second-largest region in the electrosurgical devices market. The regions covered in the global electrosurgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the electrosurgical devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The electrosurgical devices and equipment market consists of sales of surgical generators (radiofrequency, ultrasonic, electrocautery, and argon plasma equipment) and electrosurgical instruments (monopolar, bipolar, and ultrasonic instruments). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global electrosurgical devices and equipment market is segmented - 1) By Product: Electrosurgery Generators, Electrosurgery Instruments & Accessories, Argon and Smoke Management Systems  2) By End User: Hospitals, Specialized Clinics, Ambulatory Surgery Centers 3) By Application: General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery

ENT surgical devices and equipment are used in ENT surgeries by surgeons and ENT specialists.  The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, an ENT surgical navigation system, an ENT visualization system, and surgical microscopes. These devices and equipment are hand-held devices, portable devices, and fixed devices. The various end-users are hospitals, ambulatory surgical centres, and ENT clinics. The ENT surgical devices and equipment market research report is one of a series of new reports from The Business Research Company that provides ENT surgical devices and equipment market statistics, including ENT surgical devices and equipment industry global market size, regional shares, competitors with a ENT surgical devices and equipment market share, detailed ENT surgical devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the ENT surgical devices and equipment industry. This ENT surgical devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ent surgical devices and equipment market size will grow from $6.25 billion in 2022 to $6.81 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ent surgical devices and equipment market size is expected to grow to $9.11 billion in 2027 at a CAGR of 7.5%. Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market. Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market. ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted. The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space. The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management. In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany. Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent Inc., Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav. Asia-Pacific was the largest region in the global ENT surgical devices and equipment market in 2022. North America was the second-largest region in the ENT surgical devices and equipment market. The regions covered in the global ENT surgical devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The ENT surgical devices and equipment market consists of sales of balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments including the otology instrument, rhinology instrument, head and neck surgical instrument, laryngeal instrument, and other handheld instruments that are used for ENT surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ent surgical devices and equipment market is segmented - 1) By Modality: Hand-held devices, Portable devices, Fixed devices 2) By End User: Hospitals, Ambulatory surgical centers, ENT Clinics 3) By Product: Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes